論文・技術情報追加のお知らせ

①PD-1/PD-L1 inhibitors-associated cardiac adverse events: a retrospective and real-world study based on the FDA Adverse Event Reporting System (FAERS).

PD-1およびPD-L1阻害剤による心疾患系有害事象の評価研究

対象DB：FAERS

②Association between methotrexate-induced Stevens-Johnson syndrome/toxic epidermal necrolysis and furosemide: a real-world disproportionality analysis.

フロセミドとメトトレキサートを併用した場合の、SJSおよびTENの関連性評価研究

対象DB：FAERS

③High risks adverse events associated with trastuzumab emtansine and trastuzumab deruxtecan for the treatment of HER2-positive/mutated malignancies: a pharmacovigilance study based on the FAERS database.

T-DM1およびT-DXdの有害事象リスク評価研究

対象DB：FAERS

④Propofol-associated serious adverse events: an analysis of the FAERS database.

プロポフォールの有害事象リスク評価研究

対象DB：FAERS

⑤Medications affecting the IGF-1/Growth Hormone Axis, including teprotumumab, somatostatin analogues and anti-CGRP monoclonal antibodies, are associated with an elevated reporting odds of alopecia in women; a pharmacovigilance study.

ソマトスタチンアナログ、抗CGRPモノクローナル抗体による、女性における脱毛症の関連性調査研究

対象DB：FAERS

⑥Drug-induced liver injury associated with the use of newer antiseizure medications in the elderly: an analysis of data from VigiBase.

新規抗てんかん薬による薬剤性肝障害についての分析研究

対象DB：VigiBase